Guidelines for the acute coronary syndromes

被引：0
作者：
Rapaport E. [1 ]
机构：
[1] Cardiology Division, San Francisco General Hospital, University of California San Francisco, San Francisco, CA 94110
来源：
Current Cardiology Reports | 2001年 / 3卷 / 4期
关键词：
Acute Coronary Syndrome; Clopidogrel; Enoxaparin; Unstable Angina; Abciximab;
D O I：
10.1007/s11886-001-0082-1
中图分类号：
学科分类号：
摘要：
Traditional measures employed in the immediate management of patients presenting with an acute coronary syndrome have markedly reduced the risk of early death or myocardial infarction. Further incremental benefit is seen with the substitution of enoxaparin for unfractionated heparin, and in the use of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention. However, the evidence for benefit from the glycoprotwin IIb/IIIa inhibitors with medical management alone is unconvincing. Newer data also suggest an aggressive approach to the high-risk patient offers a better ultimate outcome than a conservative one. © 2001 by Current Science Inc.
引用
收藏
页码：289 / 296
页数：7
相关论文
共 35 条
  • [1] Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care 1 Part 7: The era of reperfusion, Circulation, 102, pp. 1172-1203, (2000)
  • [2] Braunwald E., Antman E.M., Beasley J.W., Et al., ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Executive summary and recommendations, Circulation, 102, pp. 1193-1209, (2000)
  • [3] Management of acute coronary syndromes without persistent ST segment elevation: Recommendations of the Task force of the European Society of Cardiology, Eur Heart J, 21, pp. 1406-1432, (2000)
  • [4] Antman E.M., Fox K.M., Guidelines for the diagnosis and management of unstable angina and non-Q-wave myocardial infarction: Proposed revisions, Am Heart J, 139, pp. 461-475, (2000)
  • [5] Gazes P.C., Mobley E., Mims J., Et al., Preinfarctional (unstable) angina-A prospective study-ten year follow-up: Prognostic significance of electrocardiographic changes, Circulation, 48, pp. 331-337, (1973)
  • [6] Calvin J.E., Klein L.W., Vandenberg E.J., Et al., Validated risk stratification model accurately predicts low risk in patients with unstable angina, J Am Coll Cardiol, 36, pp. 1803-1808, (2000)
  • [7] Antman E.M., Cohen M., Pjlm B., Et al., The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making, JAMA, 384, 7, pp. 835-842, (2000)
  • [8] Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial: Thrombolysis in Myocardial Ischemia, Circulation, 89, pp. 1545-1556, (1994)
  • [9] Boden W.E., O'rourke R.A., Crawford M.H., Et al., Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy: Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators, N Engl J Med, 338, pp. 1785-1792, (1998)
  • [10] Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomized multicentre study. Coronary Artery Disease Investigators, Lancet, 354, pp. 708-715, (1999)
1234